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characteristics were evaluated by   2 and t test. Multivariate logis-
tic modeling was used to calculate adjusted odds ratios and 95% 
confidence intervals. Answer options were coded into dichoto-
mous categories for analyses regarding willingness to go to coun-
seling (‘no’ or ‘probably not’ vs. ‘probably’ and ‘yes’) and analyses 
regarding interest in talking about specific topics (‘not at all’ or 
‘very little’ vs. ‘somewhat’ or ‘a lot’). 
 Overall, 215 of 457 COPES patients had a BDI score  6 10, 143 
of whom provided valid answers to the treatment preference ques-
tions. Those who did not were more likely to be Hispanic (14% vs. 
26%, p = 0.03), and to have major depression (18% vs. 32%, p = 
0.02). Of respondents, 63% (n = 90) had a BDI score of 10–16, and 
37% (n = 53) had a BDI score  1 16; 33% (n = 47) met criteria for 
minor depression, and 18% (n = 26) for major depression; 55% 
(n = 78) were men, 14% (n = 20) Hispanic, 13% (n = 19) African 
American, and 78% (n = 112) Caucasian.
 Fifty-two percent overall endorsed a preference for counsel-
ing; 66% with minor depression and 40% with major depression 
endorsed this preference (p = 0.061). More men versus women en-
dorsed a preference for medication, and women for counseling 
(p = 0.047). This was the only significant factor in multivariate 
analyses (adjusted odds ratios = 2.06; 95% confidence intervals 
1.04–4.10;  fig. 1 ). 
 Fifty-nine percent of patients who had initially indicated a 
preference for medication said that they ‘would’ or ‘probably 
would’ go to counseling if it were offered for free. More patients 
with minor depression versus major depression indicated a will-
ingness to utilize counseling if offered it at no cost (p = 0.061). In 
addition, more Hispanics than non-Hispanics indicated this will-
ingness (p = 0.10). Patients who indicated a willingness to go to 
free counseling were slightly younger than patients who were un-
willing (59.2  8 12.7 years vs. 61.7  8 15.7 years; p = 0.09). No 
other correlates emerged. In a logistic regression model, only ini-
tial patient preference was significant (adjusted odds ratios = 5.89; 
95% confidence intervals 2.37–14.61).
 Of the 106 patients who had indicated a willingness to go to 
counseling, the vast majority indicated an interest in talking 
about how they feel about themselves, their recreational activities, 
and their relationships. More non-Hispanics than Hispanics en-
dorsed an interest in talking about their recreational activities 
(90% vs. 72%, p = 0.06) or their relationships (90% vs. 67%, p = 
0.01). There were no other demographic differences in these in-
terests, nor were they related to depression status.
 Overall, an essentially equal number of patients with a prog-
nostically significant level of post-ACS depression endorsed a 
preference for counseling and for medication. Of those who en-
dorsed a preference for medication, over half stated that they 
would utilize counseling if offered it at no cost. While stated pref-
erences do not necessarily translate to real choices  [12] , the im-
portance of matching treatment to patients’ preference is high-
lighted by the overall success of the COPES Intervention Trial  [8] , 
along with recent research showing more rapid improvement in 
 Depression is associated with significantly poorer medical 
prognosis after acute coronary syndrome (ACS)  [1, 2] . Clinical 
trials of depression treatment in post-ACS patients have failed to 
improve event-free survival, and have for the most part shown 
only modest offsets in depression severity. Among the lessons 
learned from these efforts is that the intervention must be accept-
able to trial participants  [3] . The involvement of depressed medi-
cal patients in care decisions – e.g. between psychotherapy and 
pharmacotherapy  [4] – enhances both patient engagement and 
treatment adherence  [5, 6] , and results in significantly greater re-
ductions in depression symptom severity and major depression 
incidence  [7] , as we have recently found with ACS patients as well 
 [8] . The treatment preferences of post-ACS patients with elevated 
depressive symptoms, and correlates of these preferences, have 
not previously been examined.
 In the observational Coronary Psychosocial Evaluation Study 
(COPES)  [9] , patients at 3 northeast university hospitals were que-
ried at the time of ACS concerning their treatment preferences for 
emotional distress and problems coping with their ACS. Patients 
were  6 18 years old, spoke English or Spanish, and had scores  ! 5 
or  6 10 on the Beck Depression Inventory (BDI)  [10] within 1 
week after the ACS. Depression diagnosis was assessed by the De-
pression Interview and Structured Hamilton  [11] . Only patients 
with a BDI score  6 10, that has previously been found to carry 
post-ACS prognostic significance  [1] , were included in the current 
analyses.
 At baseline, patients were asked: (1) If your doctor advises you 
that you should  either get counseling  or take medication to help 
you cope, which one would you prefer? (2) Would you go to coun-
seling, to talk about your emotions about your heart attack and 
coping with them, if it was offered without any costs for you? In 
addition, patients were questioned concerning their interest in 
talking about 3 common elements of the depression constellation: 
one’s self, one’s activities and one’s relationships.
 Differences in treatment preferences – medication versus 
counseling – according to sociodemographic and diagnostic 
 Received: August 20, 2010 
 Accepted after revision: December 11, 2010 
 Published online: September 28, 2011 
 © 2011 S. Karger AG, Basel
 
 Accessible online at:
www.karger.com/pps 
 Psychother Psychosom 2011;80:380–382 
 DOI: 10.1159/000323615 
 Treatment Preferences among Depressed
Patients after Acute Coronary Syndrome:
The COPES Observational Cohort 
 Matthew M. Burg  a, b , Nina Rieckmann  c , Lynn Clemow  a , 
Vivian Medina  a , Joseph Schwartz  a , Karina W. Davidson  a 
 a   Columbia University School of Medicine,  New York, N.Y. , and 
 b   Yale University School of Medicine,  New Haven, Conn. , USA; 
 c   Berlin School of Public Health, Charité University Medical 
Center,  Berlin , Germany 
 Letter to the Editor 381
depression symptoms among matched versus unmatched treat-
ment recipients  [13, 14] . These findings indicate the need for fu-
ture clinical trials of post-ACS depression treatment to devise an 
intervention that accommodates participants’ treatment prefer-
ences, while providing for obstacles such as distance and travel 
(e.g. by providing treatment via phone or internet).
 The preference for counseling among women is consistent 
with previous research  [15] . The importance of this finding is un-
derlined by 2 large depression treatment trials – neither of which 
utilized patient preference – that reported a trend towards harm 
for women in the treatment arm  [16, 17] , though for the most part 
these trials utilized counseling alone. In contrast to others which 
found older individuals resisted medication  [12, 15] , age did not 
affect preference for counseling versus medication. Similarly, 
while other trials have found African Americans less likely than 
Caucasians to use counseling  [18] , this was not the case here; edu-
cation also had no effect.
 Limitations include: the small sample size, exacerbated by the 
third who did not answer preference questions, and the relatively 
small number of individuals with major depression, though the 
percent observed was consistent with prior post-ACS depression 
studies. In addition, the sample was not geographically represen-
tative, and preferences stated may differ by location. Significant 
differences in preferences due to demographic characteristics 
might have emerged with larger representation. Also the question 
regarding treatment preference did not provide for a preference 
for neither counseling nor medication, or for both, or for an as-
sessment of how insurance status affects preference, though the 
question concerning free counseling implies an effect for such 
coverage. Nonetheless, the findings of the current study, which 
are consistent with the findings of recent trials of depression treat-
ment for medical populations  [7, 12, 14, 15, 19, 20] remain to be 
implemented and tested in large trials.
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 Fig. 1. Patient preference for medication versus counseling:  ‘ If your doctor advises you that you should  either 
get counseling  or take medication to help you cope, which one would you prefer? ’ MDE = Major depressive 
episode. 
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